Home » Topics » Regulatory

Regulatory
RSS

Nippon Kayaku anticancer drugs approved for additional indications in Japan

Feb. 22, 2012

FDA approves first medical therapy for endogenous Cushing's syndrome

Feb. 20, 2012

Health Canada approves line extension for Prevnar 13

Feb. 17, 2012

FDA approves new gel for male hypogonadism

Feb. 16, 2012

Line extension for Vyvanse in U.S.

Feb. 8, 2012

Japanese approval for new formulation of Fosrenol

Feb. 3, 2012

FDA approves ivacaftor for rare form of cystic fibrosis

Feb. 1, 2012

Jentadueto approved in U.S.

Jan. 31, 2012

FDA approves first treatment for advanced BCC

Jan. 31, 2012

FDA approves axitinib for advanced renal cell carcinoma

Jan. 30, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...